Mainstream

Apellis Pharmaceuticals GAAP EPS of -$0.33 beats by $0.15, revenue of $178.5M misses by $10.15M

Apellis Pharmaceuticals GAAP EPS of -$0.33 beats by $0.15, revenue of $178.5M misses by $10.15M

Post ContentaplsRead More

You might also be interested in reading Crypto Funds Flourish In 2023: CoinShares Reports $2.2 Billion Inflow.

July 31, 2025
In Mainstream